Ousted Canopy Growth co-CEO Bruce Linton is getting back into the marijuana business in a big way, resurfacing as a senior executive, investor and adviser in three separate companies in the U.S. and Canada. Linton is joining Michigan-based Gage Cannabis Co. as executive chairman, parent company Wolverine Partners said Tuesday. Gage said in a release […]
Read MoreLatest Hemp Industry News
Global cannabis trends and game-changers: Q&A with Narbé Alexandrian, CEO of Canopy Rivers
Since taking the helm at Canopy Rivers, the investment affiliate of Canopy Growth, Narbé Alexandrian has seen the cannabis industry go from dipping its toes into global waters to plunging in headfirst.
Read More
MJBizDaily awards deadline is Saturday for cannabis leaders
The deadline for submitting nominations for Marijuana Business Daily’s inaugural MJBizDaily Awards is Saturday. The awards, which will be held during MJBizCon Week (Dec. 7-13) in Las Vegas, will recognize the top companies, individuals and organizations participating in the global cannabis industry. The MJBizDaily editorial staff will choose the winners in the awards categories that cover different […]
Read More
Week in Review: Weedmaps to end its ads for illicit cannabis, FBI probes MJ industry, MO licensing odds & more
Weedmaps plans to cease advertising unlicensed cannabis retailers, the FBI looks into public corruption in the legal marijuana industry, Missouri receives more than 2,000 medical marijuana applications – and more of the week’s top cannabis business news. Weedmaps to stop advertising unlicensed businesses The influential marijuana site Weedmaps, which is one of the most popular […]
Read More
Week in Review: Louisiana medical marijuana kickoff, Dixie-Arizona Iced Tea team, NM reciprocity & more
Sales begin in the long-delayed Louisiana medical marijuana market, MJ-infused product brand Dixie signs a licensing deal with Arizona Iced Tea’s parent, a New Mexico judge’s ruling could open MMJ sales to out-of-state patients – and more of the week’s top cannabis business news. MMJ sales begin down on the bayou After years of waiting, […]
Read More
How to avoid fantasy valuations in cannabis
Visions dance in the heads of key players of entire aisles in grocery stores and pharmacies dominated by marijuana and hemp products. Behind that, of course, there are visions of dynastic wealth.
Read More
‘Pent-up demand’ for FDA-approved cannabis drug boosts UK maker
Strong patient interest in the only federally approved CBD product in the United States helped drugmaker GW Pharmaceuticals record $72 million in revenue last quarter. Epidiolex, which is made by London’s GW Pharma (Nasdaq: GWPH), is a seizure control drug approved by the U.S. Food and Drug Administration. It has seen brisk sales and new patient enrollments since the […]
Read MoreEvent News
September Issue
The emergence of more overseas cannabis markets offers companies billions of dollars in business opportunities.Read the Issue
